Cornford P, Bellmunt J, Bolla M, Briers E, De Santis M, Gross T, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol. 2017;71(4):630–42. https://doi.org/10.1016/j.eururo.2016.08.002 Epub 2016 Aug 31. PMID: 27591931.

Article  PubMed  Google Scholar 

Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2021;79(2):263–82. https://doi.org/10.1016/j.eururo.2020.09.046 Epub 2020 Oct 7. PMID: 33039206.

CAS  Article  PubMed  Google Scholar 

Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA. 2005;294(4):433–9. https://doi.org/10.1001/jama.294.4.433 PMID: 16046649.

CAS  Article  PubMed  Google Scholar 

Kupelian PA, Mahadevan A, Reddy CA, Reuther AM, Klein EA. Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer. Urology. 2006;68(3):593–8. https://doi.org/10.1016/j.urology.2006.03.075 Epub 2006 Sep 18. PMID: 16979731.

Article  PubMed  Google Scholar 

Suardi N, Porter CR, Reuther AM, Walz J, Kodama K, Gibbons RP, et al. A nomogram predicting long-term biochemical recurrence after radical prostatectomy. Cancer. 2008;112(6):1254–63. https://doi.org/10.1002/cncr.23293 PMID: 18286530.

Article  PubMed  Google Scholar 

von Eyben FE, Picchio M, von Eyben R, Rhee H, Bauman G. 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography for prostate cancer: a systematic review and meta-analysis. Eur Urol Focus. 2018;4(5):686–93. https://doi.org/10.1016/j.euf.2016.11.002 Epub 2016 Nov 15. PMID: 28753806.

Article  Google Scholar 

Das JP, Woo S. Multiparametric prostate MRI for biochemical failure in the era of targeted PET radiotracers: point-MRI may no longer be needed in patient workup. AJR Am J Roentgenol. 2022. https://doi.org/10.2214/AJR.22.27882 Epub ahead of print. PMID: 35642763.

Bhargava P, Ravizzini G, Chapin BF, Kundra V. Imaging biochemical recurrence after prostatectomy: where are we headed? AJR Am J Roentgenol. 2020;214(6):1248–58. https://doi.org/10.2214/AJR.19.21905 Epub 2020 Mar 4. PMID: 32130049.

Article  PubMed  Google Scholar 

Afshar-Oromieh A, Holland-Letz T, Giesel FL, Kratochwil C, Mier W, Haufe S, et al. Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients. Eur J Nucl Med Mol Imaging. 2017;44(8):1258–68. https://doi.org/10.1007/s00259-017-3711-7 Epub 2017 May 12. Erratum in: Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1781. PMID: 28497198; PMCID: PMC5486817.

Article  PubMed  PubMed Central  Google Scholar 

Eiber M, Maurer T, Souvatzoglou M, Beer AJ, Ruffani A, Haller B, et al. Evaluation of hybrid 68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med. 2015;56(5):668–74. https://doi.org/10.2967/jnumed.115.154153 Epub 2015 Mar 19. Erratum in: J Nucl Med. 2016 Aug;57(8):1325. PMID: 25791990.

Article  PubMed  Google Scholar 

Rousseau C, Le Thiec M, Ferrer L, Rusu D, Rauscher A, Maucherat B, et al. Preliminary results of a 68 Ga-PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: diagnostic performance and impact on therapeutic decision-making. Prostate. 2019;79(13):1514–22. https://doi.org/10.1002/pros.23869 Epub 2019 Aug 17. PMID: 31421657.

CAS  Article  PubMed  Google Scholar 

Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, et al. 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. Lancet Oncol. 2019;20(9):1286–94. https://doi.org/10.1016/S1470-2045(19)30415-2 Epub 2019 Jul 30. Erratum in: Lancet Oncol. 2019 Nov;20(11):e613. Erratum in: Lancet Oncol. 2020 Jun;21(6):e304. PMID: 31375469; PMCID: PMC7469487.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Freitag MT, Radtke JP, Afshar-Oromieh A, Roethke MC, Hadaschik BA, Gleave M, et al. Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI. Eur J Nucl Med Mol Imaging. 2017;44(5):776–87. https://doi.org/10.1007/s00259-016-3594-z Epub 2016 Dec 17. PMID: 27988802.

CAS  Article  PubMed  Google Scholar 

Uprimny C, Kroiss AS, Decristoforo C, Fritz J, Warwitz B, Scarpa L, et al. Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions. Eur J Nucl Med Mol Imaging. 2017;44(5):765–75. https://doi.org/10.1007/s00259-016-3578-z Epub 2016 Nov 29. PMID: 27900519.

CAS  Article  PubMed  Google Scholar 

Uprimny C, Kroiss AS, Fritz J, Decristoforo C, Kendler D, von Guggenberg E, et al. Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence. Eur J Nucl Med Mol Imaging. 2017;44(10):1647–55. https://doi.org/10.1007/s00259-017-3743-z Epub 2017 Jun 6. PMID: 28589253.

CAS  Article  PubMed  Google Scholar 

Sachpekidis C, Pan L, Hadaschik BA, Kopka K, Haberkorn U, Dimitrakopoulou-Strauss A. 68Ga-PSMA-11 PET/CT in prostate cancer local recurrence: impact of early images and parametric analysis. Am J Nucl Med Mol Imaging. 2018;8(5):351–9 PMID: 30510852; PMCID: PMC6261880.

CAS  PubMed  PubMed Central  Google Scholar 

Strauss DS, Sachpekidis C, Kopka K, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A. Pharmacokinetic studies of [68 Ga]Ga-PSMA-11 in patients with biochemical recurrence of prostate cancer: detection, differences in temporal distribution and kinetic modelling by tissue type. Eur J Nucl Med Mol Imaging. 2021. https://doi.org/10.1007/s00259-021-05420-1 Epub ahead of print. PMID: 34110436.

Haupt F, Dijkstra L, Alberts I, Sachpekidis C, Fech V, Boxler S, et al. 68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol. Eur J Nucl Med Mol Imaging. 2020;47(3):624–31. https://doi.org/10.1007/s00259-019-04548-5 Epub 2019 Nov 1. PMID: 31673789.

CAS  Article  PubMed  Google Scholar 

Uprimny C, Bayerschmidt S, Kroiss AS, Fritz J, Nilica B, Svirydenka H, et al. Early injection of furosemide increases detection rate of local recurrence in prostate cancer patients with biochemical recurrence referred for 68Ga-PSMA-11 PET/CT. J Nucl Med. 2021:jnumed.120.261866. https://doi.org/10.2967/jnumed.120.261866 Epub ahead of print. PMID: 33712533.

Alberts I, Niklas-Hünermund J, Sachpekidis C, Zacho HD, Mingels C, Dijkstra L, et al. Combination of forced diuresis with additional late imaging in 68Ga-PSMA-11 PET/CT: effects on lesion visibility and radiotracer uptake. J Nucl Med. 2021;62(9):1252–7. https://doi.org/10.2967/jnumed.120.257741 Epub 2021 Feb 5. PMID: 33547214.

CAS  Article  PubMed  Google Scholar 

Rahbar K, Afshar-Oromieh A, Bögemann M, Wagner S, Schäfers M, Stegger L, et al. 18F-PSMA-1007 PET/CT at 60 and 120 minutes in patients with prostate cancer: biodistribution, tumour detection and activity kinetics. Eur J Nucl Med Mol Imaging. 2018;45(8):1329–34. https://doi.org/10.1007/s00259-018-3989-0 Epub 2018 Mar 14. PMID: 29541812.

CAS  Article  PubMed  Google Scholar 

Giesel FL, Knorr K, Spohn F, Will L, Maurer T, Flechsig P, et al. Detection efficacy of 18F-PSMA-1007 PET/CT in 251 patients with biochemical recurrence of prostate cancer after radical prostatectomy. J Nucl Med. 2019;60(3):362–8. https://doi.org/10.2967/jnumed.118.212233 Epub 2018 Jul 24. PMID: 30042163; PMCID: PMC6424235.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Afshar-Oromieh A, Haberkorn U, Schlemmer HP, Fenchel M, Eder M, Eisenhut M, et al. Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Eur J Nucl Med Mol Imaging. 2014;41(5):887–97. https://doi.org/10.1007/s00259-013-2660-z Epub 2013 Dec 19. PMID: 24352789.

CAS  Article  PubMed  Google Scholar 

Freitag MT, Radtke JP, Hadaschik BA, Kopp-Schneider A, Eder M, Kopka K, et al. Comparison of hybrid (68)Ga-PSMA PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer. Eur J Nucl Med Mol Imaging. 2016;43(1):70–83. https://doi.org/10.1007/s00259-015-3206-3 Epub 2015 Oct 28. PMID: 26508290.

CAS  Article  PubMed  Google Scholar 

Guberina N, Hetkamp P, Ruebben H, Fendler W, Grueneisen J, Suntharalingam S, et al. Whole-body integrated [68Ga]PSMA-11-PET/MR imaging in patients with recurrent prostate cancer: comparison with whole-body PET/CT as the standard of reference. Mol Imaging Biol. 2020;22(3):788–96. https://doi.org/10.1007/s11307-019-01424-4 PMID: 31482413.

CAS  Article  PubMed  Google Scholar 

Jentjens S, Mai C, Ahmadi Bidakhvidi N, De Coster L, Mertens N, Koole M, et al. Prospective comparison of simultaneous [68Ga]Ga-PSMA-11 PET/MR versus PET/CT in patients with biochemically recurrent prostate cancer. Eur Radiol. 2022;32(2):901–11. https://doi.org/10.1007/s00330-021-08140-0 Epub 2021 Aug 10. PMID: 34374802.

CAS  Article  PubMed  Google Scholar 

McMahon CJ, Rofsky NM, Pedrosa I. Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging. Radiology. 2010;254:31–46.

Article  Google Scholar 

Sawicki LM, Kirchner J, Buddensieck C, Antke C, Ullrich T, Schimmöller L, et al. Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy. Eur J Nucl Med Mol Imaging. 2019;46(7):1542–50. https://doi.org/10.1007/s00259-019-04308-5 Epub 2019 Mar 16. PMID: 30879122.

CAS  Article  PubMed  Google Scholar 

PMOD. Iso-contour Mode (Pseudo-Snake). Available at: http://www.pmod.com/files/download/v31/doc/pbas/4729.htm. Retrieved October 28, 2021.

Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31(3):1116–28. https://doi.org/10.1016/j.neuroimage.2006.01.015 Epub 2006 Mar 20. PMID: 16545965.

Article  PubMed  Google Scholar 

Hamlett A, Ryan L, Serrano-Trespalacios P, Wolfinger R. Mixed models for assessing correlation in the presence of replication. J Air Waste Manag Assoc. 2003;53(4):442–50. https://doi.org/10.1080/10473289.2003.10466174 PMID: 12708508.

CAS  Article  PubMed  Google Scholar 

Irimata K, Wakim P, Li X. Estimation of correlation coefficient in data with repeated measures. In: SAS global forum proceedings; 2018. p. 2424–018.

Google Scholar 

Huo H, Shen S, He D, Liu B, Yang F. Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies. Prostate Cancer Prostatic Dis. 2022. https://doi.org/10.1038/s41391-022-00581-y Epub ahead of print. PMID: 35931759.

Rauscher I, Maurer T, Beer AJ, Graner FP, Haller B, Weirich G, et al. Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage lymphadenectomy. J Nucl Med. 2016;57(11):1713–9. https://doi.org/10.2967/jnumed.116.173492 Epub 2016 Jun 3. PMID: 27261524.

CAS  Article  PubMed  Google Scholar 

Afshar-Oromieh A, Vollnberg B, Alberts I, Bähler A, Sachpekidis C, Dijkstra L, et al. Comparison of PSMA-ligand PET/CT and multiparametric MRI for the detection of recurrent prostate cancer in the pelvis. Eur J Nucl Med Mol Imaging. 2019;46(11):2289–97. https://doi.org/10.1007/s00259-019-04438-w Epub 2019 Jul 27. PMID: 31350604.

Article  PubMed